Somatorelin
- Generic Name
- Somatorelin
- Drug Type
- Biotech
- CAS Number
- 83930-13-6
- Unique Ingredient Identifier
- 4UR7N9Z9MM
- Background
Somatorelin has been used in trials studying the treatment of Aging, Elderly, Sleep Disorders, Hormone Deficiency, and Mild Cognitive Impairment.
- Associated Conditions
- Human Growth Hormone Deficiency
The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol
Phase 3
- Conditions
- Embryo's Genetic and Chromosomal Quality
- Interventions
- First Posted Date
- 2012-07-10
- Last Posted Date
- 2012-07-10
- Lead Sponsor
- European Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT01636505
- Locations
- 🇮🇹
European Hospital, Rome, Italy
Six Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
- First Posted Date
- 2008-12-11
- Last Posted Date
- 2017-04-27
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 5
- Registration Number
- NCT00807365
- Locations
- 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
- First Posted Date
- 1999-11-03
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- University of Washington
- Registration Number
- NCT00000380
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath